Luyan Pharma Co Ltd (002788) — Capital Reinvestment Ratio

Latest as of September 2025: 0.64x

Luyan Pharma Co Ltd (002788) has a Capital Reinvestment Ratio of 0.64x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥118.98 Million) in capital expenditures (CN¥76.55 Million). See Luyan Pharma Co Ltd (002788) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.64x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥118.98 Million
CNY

Capital Expenditures

CN¥76.55 Million
CNY

Data as of

Sep 2025
Most recent filing

Luyan Pharma Co Ltd Capital Reinvestment Ratio (2011–2025)

This chart tracks Luyan Pharma Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check 002788 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Luyan Pharma Co Ltd (2011–2025)

Year-by-year Capital Reinvestment Ratio for Luyan Pharma Co Ltd from 2011 to 2025. For live market cap and broader valuation context, see Luyan Pharma Co Ltd (002788) total market value.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.34x CN¥688.40 Million CN¥233.74 Million ▼ -45.7%
2024 0.63x CN¥577.48 Million CN¥361.12 Million ▲ +54.7%
2023 0.40x CN¥1.31 Billion CN¥529.21 Million ▼ -71.3%
2022 1.41x CN¥232.19 Million CN¥327.58 Million ▼ -36.1%
2020 2.21x CN¥77.22 Million CN¥170.62 Million ▲ +109.2%
2018 1.06x CN¥126.77 Million CN¥133.88 Million ▼ -99.5%
2015 192.80x CN¥219.31K CN¥42.28 Million ▲ +40183.8%
2014 0.48x CN¥177.89 Million CN¥85.14 Million ▼ -60.6%
2011 1.22x CN¥28.01 Million CN¥34.05 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow